Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol

Psychopharmacology

Volumn 127, Issue 4, 1996, Pages 337-345

  Egan, Michael F ^a   Hurd, Yasmin ^b   Ferguson, Jennifer ^a   Bachus, Susan E ^a   Hamid, Emad H ^a   Hyde, Thomas M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Dynorphin; Enkephalin; Haloperidol; Substance P; Tardive dyskinesia; Vacuous chewing movements

Indexed keywords

DYNORPHIN; ENKEPHALIN; HALOPERIDOL; HALOPERIDOL DECANOATE; MESSENGER RNA; NEUROLEPTIC AGENT; NEUROPEPTIDE; SUBSTANCE P;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; EXTRAPYRAMIDAL SYMPTOM; GLOBUS PALLIDUS; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MASTICATION; NEUROCHEMISTRY; NONHUMAN; OROFACIAL DYSKINESIA; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TARDIVE DYSKINESIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; CORPUS STRIATUM; DYNORPHINS; DYSKINESIA, DRUG-INDUCED; ENKEPHALINS; HALOPERIDOL; IN SITU HYBRIDIZATION; MALE; MASTICATION; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SUBSTANCE P;

EID: 0029972208     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050095     Document Type: Article

References (64)

1. APA Task Force on Tardive Dyskinesia (1992) Tardive dyskinesia - a task force report of the American Psychiatric Association. APA Press, Washington DC
2. Bannon MJ, Lee JM, Giraud P, Young A, Affolter H-U, Bonner TI (1986) Dopamine antagonist haloperidol decreases substance P, substance K, and preprotachykinin mRNAs in rat striatonigral neurons. J Biol Chem 261: 6640-6642
3. Bannon, MJ, Elliot PJ, Bunney EB (1987) Striatal tachykinin biosynthesis: regulation of mRNA and peptide levels by dopamine agonists and antagonists. Mol Brain Res 3: 31-37
4. Civelli O, Douglass J, Goldstein A, Herbert E (1985) Sequence and expression of the rat prodynorphin gene. Proc Natl Acad Sci USA 82: 4291-4295
5. Crossman AE (1990) A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment. Move Disord 5: 100-108
6. Cruz CJ, Beckstead RM (1988) Quantitative radioimmunocytochemical evidence that haloperidol and SCH 23390 induce opposite changes in substance P levels of rat substantia nigra. Brain Res 457: 29-43
7. Daunais JB, Roberts DCS, McGinty JF (1993) Cocaine self-administration incrases preprodynorphin, but not c-fos, mRNA in rat striatum. Neuroreport 4: 543-546
8. DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13: 281-289
9. Egan MF, Hurd Y, Hyde TM, Weinberger DR, Wyatt RJ, Kleinman JE (1994a) Alterations in dopamine receptor and neuropeptide gene expression in striatonigral and striatopallidal neurons in rats with vacuous chewing movements induced by chronic treatment with haloperidol. Synapse 18: 178-189
10. 1 antagonist SCH23390 on vacuous chewing movements and striatal neuropeptide mRNA following long term haloperidol decanoate. Soc Neurosci Abstr 513: 12
11. Egan MF, Hyde TM, Kleinman JE, Wyatt RJ (1995a) Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose. Psychopharmacology 117: 74-81
12. Egan MF, Ferguson J, Hyde TM (1995b) Effects of habituation of assessment on vacuous chewing movements in rats treated with long term haloperidol decanoate. Pharmacol Biochem Behav 53: 401-410
13. 2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 250: 1429-1432
14. Gerfen CR, McGinty JF, Young WS (1991) Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci 11[4]: 1016-1031
15. Glassman RB, Glassman HN (1980) Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: implication for models of tardive dyskinesia. Psychopharmacology 69: 19-25
16. Glenthoj B, Hemmingsen R (1989) Intermittent neuroleptic treatment induces long lasting abnormal mouthing in the rat. Eur J Pharmacol 164: 393-396
17. Gunne LM, Häggström J-E (1983) Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia. Psychopharmacology 81: 191-194
18. Gunne LM, Growdon J, Glaeser B (1982) Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology 77: 134-139
19. Gunne LM, Andersson U, Bondesson U, Johansson P (1986) Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration. Pharmacol Biochem Behav 25: 897-901
20. Gunne LM, Bachus SE, Gale K (1988) Oral movements induced by interference with nigral GABA neurotransmission: relationship to tardive dyskinesias. Psychopharmacology 100: 459-469
21. Hanson G, Alphs L, Pradhan S, Lovenberg W (1981) Response of striatonigral substance P systems to a dopamine receptor agonist and antagonist. Neuropharmacology 20: 541-548
22. Hong JS, Yang H-Y, T, Costa E (1978) Substance P content of substantia nigra after chronic treatment with antischizophrenic drugs. Neuropharmacology 17: 83-85
23. Hurd YL, Herkenham M (1992) Influence of a single injection of cocaine, amphetamine, or GBR 12909 on mRNA expression of striatal neuropeptides. Brain Res [Mol Brain Res] 16: 97-104
24. Hurd YL, Brown EE, Finlay JM, Fibiger HC, Gerfen CR (1992) Cocaine self-administration differentially alters mRNA expression of striatal peptides. Mol Brain Res 13: 165-170
25. Hyde TM, Egan MF, Wing LL, Wyatt RJ, Weinberger DR, Kleinman JE (1995) Persistent catalepsy predicts the development of dyskinesias in rats treated with chronic injections of haloperidol decanoate. Psychopharmacology 118: 142-149
26. Jeste DV, Lohr JB, Clark, K, Wyatt RJ (1988) Pharmacological treatments of tardive dyskinesia in the 1980s. J Clin Psychopharmacol 8: 38S-48S
27. Jiang H-K, McGinty JF, Hong JS (1990) Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes. Brain Res 507: 57-64
28. Jicha GA, Salamone JD (1991) Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: possible relation to parkinsonian symptoms. J Neurosci 11[12]: 3822-3829
29. Johansson P, Casey DE, Gunne LM (1986) Dose-dependent increases in rat spontaneous chewing rates during long-term administration of haloperidol but not clozapine. Psychopharmacol Bull 22: 1017-1019
30. 2 agonist on oral movements in rats. Eur J Pharmacol 134: 83-88
31. Jorgensen HA, Andreassen OA, Hole K (1994) The relationship between motor effects in rats following acute and chronic haloperidol treatment. Psychopharmacology 116: 89-92
32. Kaneda H, Shirakawa O, Dale J, Goodman L, Bachus SE, Tamminga CA (1992) Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats. Eur J Pharmacol 212: 43-49
33. Krause JE, Chirgwin JM, Carter MS, Xu ZS, Hershey AD (1987) Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A. Proc Natl Acad Sci USA 84: 881-885
34. Li S, Sivam SP, Hong JS (1986) Regulation of the concentration of dynorphin A(1-8) in the striatonigral pathway by the dopaminergic system. Brain Res 398: 390-392
35. Li SJ, Sivam SP, McGinty JF, Huang YS, Hong JS (1987) Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway. J Pharmacol Exp Ther 243: 792-798
36. Mithani S, Atmadja S, Baimbridge KG, Fibiger HC (1987) Neuroleptic-induced oral dyskinesias: effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities. Psychopharmacology 93: 94-100
37. 2 antagonists. Neuroscience 25[2]: 525-532
38. Nisenbaum LK, Kitai ST, Gerfen CR (1994) Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNAs following striatal dopamine denervation: effects of systemic and central administration of quinpirole and scopalamine. Neuroscience 63: 435-449
39. Nylander I, Terenius L (1986) Chronic haloperidol and clozapine differentially affect dynorphin peptides and substance P in basal ganglia of the rat. Brain Res 380: 34-41
40. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, New York
41. Peterson MR, Robertson HA (1984) Effect of dopaminergic agents on levels of dynorphin (1-8) in rat striatum. Prog Neuro-Psychopharmacol Biol Psychiatry 8: 725-728
42. 2 dopaminergic regulation of striatal preproenkephalin mRNA levels is mediated at least in part through cholinergic interneurons. Mol Brain Res 13: 35-41
43. Quirion R, Gaudreau P, Martel J-C, St Pierre S, Zamir N (1985) Possible interactions between dynorphin and dopaminergic systems in rat basal ganglia and substantia nigra. Brain Res 331: 358-362
44. Radke JM, MacLennan AJ, Vincent SR, Fibiger HC (1988) Comparison between short- and long-term haloperidol administration on somatostatin and substance P concentrations in the rat brain. Brain Res 445: 55-60
45. 1 stimulation. Life Sci 33: 2479-2482
46. Rosengarten H, Schweitzer JW, Friedhoff AJ (1986) Selective dopamine D-2 receptor reduction enhances a D-1 mediated oral dyskinesia in rats. Life Sci 39: 29-35
47. Rosengarten H, Schweitzer JW, Friedhoff AJ (1994) Possible genetic factors underlying the pathophysiology of tardive dyskinesia. Pharmacol Biochem Behav 49(3): 663-667
48. Rupniak NMJ, Jenner P, Marsden CD (1983) Cholinergic manipulation of perioral behaviour induced by chronic neuroleptic administration to rats. Psychopharmacology 79: 226-230
49. Rupniak NMJ, Jenner P, Marsden CD (1985) Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats. Psychopharmacology 85: 71-79
50. Rupniak NMJ, Jenner P, Marsden CD (1986) Acute dystonia induced by neuroleptic drugs. Psychopharmacology 88: 403-419
51. Salamone JD, Johnson CJ, McCullough LD, Steinpreis RE (1990) Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat. Psychopharmacology 102: 529-534
52. See R, Ellison G (1990a) Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats. Psychopharmacology 100: 404-412
53. See R, Ellison G (1990b) Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia. Eur J Pharmacol 181: 175-186
54. Shibata K, Haverstick DM, Bannon MJ (1990) Tachykinin gene expression in rat limbic nuclei: modulation by dopamine antagonists. J Pharmacol Exp Ther 255: 388-392
55. Steinpreis RE, Baskin P, Salamone JD (1993) Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine. Psychopharmacology 111: 99-105
56. 2 receptor antagonists. Psychopharmacology 98: 327-379
57. Tamminga CA, Dale JM, Goodman L, Kaneda H, Kaneda N (1990) Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains. Psychopharmacology 102: 474-478
58. Waddington JL (1990) Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia. Psychopharmacology 101: 431-447
59. Waddington JL, Molloy AG (1987) The status of late-onset vacuous chewing/perioral movements during long-term neuroleptic treatment in rodents: tardive dyskinesia or dystonia? Psychopharmacology 91: 136-137
60. Waddington JL, Cross AJ, Gamble SJ, Bourne RC (1983) Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment. Science 220: 530-532
61. Waddington JL, Youssef HA, O'Boyle KM, Molloy AG (1986a) A reappraisal of abnormal involuntary movements (tardive dyskinesia) in schizophrenia and other disorders: animal models and alternative hypotheses. In: Winlow W, Markstein T (eds) The neurobiology of dopamine systems. Manchester University Press, Manchester, pp 266-286
62. Waddington JL, Molloy AG, O'Boyle KM, Youssef HA (1986b) Spontaneous and drug-induced dyskinesias in rodents in relation to ageing and long-term neuroleptic treatment: relationship to tardive dyskinesia. In: Shagass C, Josiassen RC, Bridger W, Weiss K, Stoff D, Simpson G (eds) Biological psychiatry 1985. Elsevier, N.Y., pp 1151-1153
63. Yoshikawa K, Williams C, Sabol SL (1984) Rat brain preproenkephalin mRNA. J Biol Chem 259: 14301-14308
64. Young SW, Bonner TI, Brann MR (1986) Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci USA 83: 9827-9831